RSMDF (ResMed) Short Percentage of Float


RSMDF ResMed Inc RSMDF
94 GF Score
Price $16.72
GF Value $23.97
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is ResMed Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

RSMDF vs MDLN, WST, BDX: Short Percentage of Float Comparison

For the Medical Instruments & Supplies subindustry, ResMed's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ResMed Short Percentage of Float vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where ResMed's Short Percentage of Float falls into.


RSMDF
94GF Score
ResMed Inc RSMDF
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ResMed (RSMDF) Overvalued in 2026?

Based on GuruFocus' analysis, ResMed stock appears to be undervalued. The current stock price of $16.72 is trading 30.2% below its estimated GF Value™ of $23.97. GuruFocus considers ResMed to be Significantly Undervalued.

Key valuation signals for RSMDF:

  • Short Percentage of Float:
  • GF Value™: $23.97 vs. price of $16.72 (30.2% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the RSMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ResMed Business Description

Address 9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
94GF Score

Get the complete analysis for RSMDF

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.72
Price
$23.97
GF Value